Biotransform project announces doctoral and researcher vacancies across partner institutions

From 1 November 2025 to 31 October 2029, Rīga Stradiņš University (RSU) is partnering with leading universities and research institutes with expertise spanning clinical research, pharmacology, metabolite profiling, microbiome science, colon simulation models and translational biopharmaceutics, including NKUA-Med, NKUA-Pharm, MedUniGraz, UGraz, Teagasc, UCC, UAntwerp, UBath, ICL, to implement the Biotransform project.

Applications are now open for four doctoral candidate (DC) vacancies within the framework of the project:

• DC1 open position in Antwerp, Belgium
• DC2 open position in Antwerp, Belgium
• DC7 open position in Cork, Ireland
• DC11 open position at the Latvian Institute of Organic Synthesis (LIOS), Latvia

RSU will be hiring a doctoral student for the eighth phase of the project (DC8 open position).